JP2009527503A5 - - Google Patents

Download PDF

Info

Publication number
JP2009527503A5
JP2009527503A5 JP2008555561A JP2008555561A JP2009527503A5 JP 2009527503 A5 JP2009527503 A5 JP 2009527503A5 JP 2008555561 A JP2008555561 A JP 2008555561A JP 2008555561 A JP2008555561 A JP 2008555561A JP 2009527503 A5 JP2009527503 A5 JP 2009527503A5
Authority
JP
Japan
Prior art keywords
residue
peg
alternatively
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008555561A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009527503A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AT2007/000096 external-priority patent/WO2007095661A1/en
Publication of JP2009527503A publication Critical patent/JP2009527503A/ja
Publication of JP2009527503A5 publication Critical patent/JP2009527503A5/ja
Pending legal-status Critical Current

Links

JP2008555561A 2006-02-23 2007-02-23 ペプチドおよびペプチド誘導体、それらの製造ならびに治療上および/または予防上使用可能な医薬組成物を調製するためのそれらの使用 Pending JP2009527503A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT3022006 2006-02-23
PCT/AT2007/000096 WO2007095661A1 (en) 2006-02-23 2007-02-23 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition

Publications (2)

Publication Number Publication Date
JP2009527503A JP2009527503A (ja) 2009-07-30
JP2009527503A5 true JP2009527503A5 (enExample) 2009-11-26

Family

ID=38037441

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008555561A Pending JP2009527503A (ja) 2006-02-23 2007-02-23 ペプチドおよびペプチド誘導体、それらの製造ならびに治療上および/または予防上使用可能な医薬組成物を調製するためのそれらの使用

Country Status (15)

Country Link
US (3) US20080004220A1 (enExample)
EP (1) EP1987063B1 (enExample)
JP (1) JP2009527503A (enExample)
AT (1) ATE443722T1 (enExample)
AU (1) AU2007219032B2 (enExample)
CA (1) CA2641909A1 (enExample)
CY (1) CY1109537T1 (enExample)
DE (1) DE602007002553D1 (enExample)
DK (1) DK1987063T3 (enExample)
ES (1) ES2333374T3 (enExample)
PL (1) PL1987063T3 (enExample)
PT (1) PT1987063E (enExample)
SI (1) SI1987063T1 (enExample)
WO (1) WO2007095661A1 (enExample)
ZA (1) ZA200807027B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20060366A1 (it) * 2006-03-01 2007-09-02 C4T S C A R L Composti organo tiopirosfosfati metodo per prepararli e composizioni che li contengono
WO2009038729A2 (en) * 2007-09-17 2009-03-26 Regenerx Biopharmaceuticals, Inc. Compositions and methods utilizing fibrin beta chain fragments of the bbeta chain of fibrinogen
WO2010043444A2 (en) * 2008-10-15 2010-04-22 Fibrex Medical Research & Development Gmbh Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof
US20100152832A1 (en) * 2008-12-12 2010-06-17 Medtronic Vascular, Inc. Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta
PL2464655T3 (pl) * 2009-08-11 2017-08-31 Biocon Limited Procesy chromatograficzne
WO2011060018A2 (en) * 2009-11-13 2011-05-19 Ikaria Development Subsidiary Two Llc Compositions and methods for using peptides, modified peptides, peptidomimetics and fibrin derivatives
US9405444B2 (en) * 2010-10-01 2016-08-02 Z124 User interface with independent drawer control
US12171802B2 (en) 2016-06-02 2024-12-24 University Of Maryland, Baltimore Compositions for inhibiting fibrin-VLDL receptor-dependent inflammation and methods of treatment
WO2019011879A1 (en) 2017-07-09 2019-01-17 Rainer Henning THERAPEUTIC AGENT FOR THE TREATMENT OF CAPILLARY LEAK SYNDROME
EP3912679A1 (en) 2020-05-19 2021-11-24 Johann Wolfgang Goethe-Universität Frankfurt am Main Bbeta-15-42 for the treatment of viral endothelitis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4973577A (en) * 1986-04-04 1990-11-27 The Salk Institute For Biological Studies FSH-releasing peptides
US5637677A (en) * 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
US5965107A (en) 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
AU6522400A (en) * 1999-08-10 2001-03-05 Imarx Therapeutics, Inc. Targeted thrombolytic agents
SI1341819T1 (sl) * 2000-12-12 2006-10-31 Fibrex Medical Res & Dev Gmbh Uporaba fibrinskih/fibrinogenskih peptidov in proteinov za pripravo zdravila
KR101399678B1 (ko) * 2003-01-15 2014-05-27 추가이 세이야쿠 가부시키가이샤 이량체화 펩티드
SI1691827T1 (sl) * 2004-06-25 2010-01-29 Fibrex Medical Res & Dev Gmbh Uporaba peptidov, izvedenih iz Bbeta-verige človeškega fibrinogena, za zdravljenje šoka

Similar Documents

Publication Publication Date Title
JP2010065046A5 (enExample)
JP2010521514A5 (enExample)
JP2007530441A5 (enExample)
JP2012512898A5 (enExample)
JP2009537624A5 (enExample)
JP2010535870A5 (enExample)
JP2010519289A5 (enExample)
JP2012510502A5 (enExample)
JP2009535358A5 (enExample)
MX2010008101A (es) Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica.
JP2013531659A5 (enExample)
JP2004538303A5 (enExample)
JP2009539914A5 (enExample)
JP2010533478A5 (enExample)
JP2009541288A5 (enExample)
RU2014148530A (ru) Производные дипептида лизин-глутаминовая кислота
JP2008201787A5 (enExample)
JP2008509928A5 (enExample)
JP2007534702A5 (enExample)
JP2009538336A5 (enExample)
WO2008069917A3 (en) Novel cyclic peptides
JP2011521902A5 (enExample)
MX2010012042A (es) Peptidos, peptidomimeticos y derivados de los mismos, su fabricacion asi como su uso para preparar una composicion farmaceutica terapeutica y/o preventivamente activa.
JP2017518363A5 (enExample)
JP2010512326A5 (enExample)